$1.02 Billion is the total value of CLOUGH CAPITAL PARTNERS L P's 106 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RVT | ROYCE VALUE TR INC | $2,908,000 | +1.2% | 208,900 | 0.0% | 0.28% | +13.5% | |
| EQ | EQUILLIUM INC | $1,768,000 | -29.2% | 312,300 | 0.0% | 0.17% | -20.6% | |
| LLY | LILLY ELI & CO | $976,000 | -14.7% | 8,813 | 0.0% | 0.10% | -4.0% | |
| DPG | DUFF & PHELPS GLB UTL INC FD | $906,000 | +2.5% | 59,200 | 0.0% | 0.09% | +15.6% | |
| EL | LAUDER ESTEE COS INCcl a | $586,000 | +10.6% | 3,200 | 0.0% | 0.06% | +23.9% | |
| ZF | VIRTUS TOTAL RETURN FUND INC | $305,000 | +5.5% | 28,750 | 0.0% | 0.03% | +20.0% | |
| TSLF | THL CR SR LN FD | $296,000 | -0.7% | 19,437 | 0.0% | 0.03% | +11.5% | |
| DNIF | DIVIDEND & INCOME FUND | $217,000 | +1.4% | 18,800 | 0.0% | 0.02% | +10.5% | |
| JRO | NUVEEN FLTNG RTE INCM OPP FD | $154,000 | +1.3% | 15,803 | 0.0% | 0.02% | +15.4% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Charles I. Clough, Jr. #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BK OF AMERICA CORP | 40 | Q2 2024 | 5.0% |
| MICROSOFT CORP | 38 | Q2 2024 | 7.6% |
| JPMORGAN CHASE & CO. | 36 | Q2 2024 | 3.2% |
| TRANSDIGM GROUP INC | 35 | Q2 2024 | 3.9% |
| D R HORTON INC | 35 | Q2 2024 | 3.2% |
| CITIGROUP INC | 33 | Q2 2021 | 5.8% |
| VERTEX PHARMACEUTICALS INC | 32 | Q2 2023 | 1.6% |
| JAZZ PHARMACEUTICALS PLC | 32 | Q3 2023 | 1.6% |
| AMAZON COM INC | 31 | Q2 2024 | 6.0% |
| STARWOOD PPTY TR INC | 31 | Q2 2024 | 5.5% |
View CLOUGH CAPITAL PARTNERS L P's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Checkmate Pharmaceuticals, Inc. | February 14, 2022 | 1,137,764 | 5.3% |
| Correvio Pharma Corp.Sold out | February 24, 2020 | 0 | 0.0% |
| Cardiome Pharma Corp | April 27, 2018 | 2,058,763 | 5.9% |
| CARVANA CO. | April 27, 2018 | 1,072,050 | 3.6% |
| HEALTHWAYS, INC | January 12, 2016 | 1,850,289 | 5.1% |
| Kura Oncology, Inc. | January 12, 2016 | 1,076,333 | 5.0% |
| VERACYTE, INC. | January 12, 2016 | 1,049,054 | 3.8% |
| Solar Senior Capital Ltd. | February 11, 2013 | 325,093 | 2.8% |
| MAGAL SECURITY SYSTEMS LTDSold out | March 23, 2011 | 0 | 0.0% |
| BIOSPHERE MEDICAL INCSold out | February 10, 2011 | 0 | 0.0% |
View CLOUGH CAPITAL PARTNERS L P's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
View CLOUGH CAPITAL PARTNERS L P's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.